Sort
85,873 grants matching “alzheimers”
Identifying and Correcting Dementia-Associated Changes in the Blood-Brain Barrier
$2,366,000Lee L Rubin · Harvard University · RF1 · FY2020 · NS
ADMINISTRATIVE CORE
$2,365,884Paul S. Aisen · University Of California, San Diego · U19 · FY2019 · AG
Biomarkers of neurodegeneration in the US and India: A cross-national evaluation of the biological underpinnings of ADRD
$2,365,042Alden L. Gross · Johns Hopkins University · RF1 · FY2024 · AG
Alzheimer's Prevention Initiative ADAD Colombia Trial
$2,364,038Eric M Reiman · Banner Health · R01 · FY2021 · AG
Synaptopathy and Pathogenesis in Frontotemporal Dementia: Role of CYLD
$2,364,013Wei-Dong Yao · Upstate Medical University · RF1 · FY2023 · AG
Genomic and Biological Studies of APOE ε2 in Alzheimer Disease
$2,363,896Lindsay A. Farrer · Boston University Medical Campus · RF1 · FY2017 · AG
Structure and Genesis of tau Aggregates
$2,363,370Jeff A Kuret · Ohio State University · RF1 · FY2017 · AG
Mouse BIRN
$2,363,204Arthur W Toga · University Of California Los Angeles · U24 · FY2008 · RR
MOUSE BIRN
$2,363,204Arthur W Toga · University Of California Los Angeles · U24 · FY2008 · RR
Examining the Persistence of Neurocognitive Benefits of Exercise
$2,362,885Kirk I Erickson · Adventhealth Orlando · R01 · FY2023 · AG
Amyloid elimination by Hsp104 and substrate-optimized variants
$2,362,500James Shorter · University Of Pennsylvania · DP2 · FY2007 · OD
Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond
$2,362,233John Robert Warren · University Of Minnesota · R01 · FY2019 · AG
Health and Retirement Study: Years 29-34
$2,361,446David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2020 · AG
Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease
$2,360,820Towfique Raj · Icahn School Of Medicine At Mount Sinai · RF1 · FY2021 · AG
"What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementias
$2,360,353Jonathan Graff-Radford · Mayo Clinic Rochester · RF1 · FY2021 · AG
Dissecting the modulatory functions of interleukin-17 in Alzheimer's Disease
$2,359,602Jun R. Huh · Harvard Medical School · RF1 · FY2023 · AG
Molecular And Pharmacological Studies Of Dopamine Receptors
$2,359,595David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)
$2,359,595Mark Andrew Espeland · Wake Forest University Health Sciences · R01 · FY2018 · AG
Einstein Aging Study
$2,359,368Albert Einstein Col Of Med Yeshiva Univ · P01 · FY2004 · AG
ALZHEIMERS DISEASE RESEARCH CENTER
$2,358,910Mount Sinai School Of Medicine Of Nyu · P50 · FY2002 · AG
Epigenetic Aging Cognitive Function and Exercise in Older Adults
$2,358,537Yvette P Conley · University Of Pittsburgh At Pittsburgh · RF1 · FY2024 · AG
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
$2,358,523Thomas M Wisniewski · New York University School Of Medicine · P01 · FY2023 · AG
Single cell analysis of the kinome
$2,357,600Long Cai · California Institute Of Technology · DP1 · FY2025 · NS
Understanding neuronal dysfunction in Down Syndrome using assembloids and xenotransplanted cortical organoids
$2,357,335Ella Zeldich · Boston University Medical Campus · RF1 · FY2024 · AG
Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD cohort
$2,357,335Marilyn S Albert · Johns Hopkins University · U01 · FY2010 · AG